We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System (CNS) disorders such as Alzheimer's Disease. Aphios®, which means "virus-free" in Greek, was founded in 1993 as a Delaware C corporation. The company was founded by Dr. Trevor P. Castor, President and CEO, to develop enabling technology platforms around the delivery and viral safety of biologics such as human plasma and recombinant therapeutics, hence its "virus-free" name. At its founding, the Company elected to spend about 10% of its research activities on investigating natural therapeutics. This interest has evolved to the realization that in order to solve the problems of cancer and aging, we have to look to nature, marine organisms and terrestrial plants that have learned how to control cell growth and cancerous mutation, often living for hundreds to thousands of years.
Woburn, US
Size (employees)
13 (est)+9%
Aphios was founded in 1993 and is headquartered in Woburn, US
Report incorrect company information

Key People/Management at Aphios

Trevor Castor

Trevor Castor

President and Chief Executive Officer
Joseph Faris

Joseph Faris

Chief Financial Officer
James Falese

James Falese


Aphios Office Locations

Aphios has an office in Woburn
Woburn, US (HQ)
3 Gill St
Show all (1)
Report incorrect company information

Aphios Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$2.4 m

Latest funding size

$2.40 m

Time since last funding

6 years ago
Aphios's latest funding round in January 2012 was reported to be $2.4 m. In total, Aphios has raised $2.4 m
Report incorrect company information